CIDRAP newsletters options
WHO praises pandemic vaccine donations
(CIDRAP News) The first wave of H1N1 vaccine will probably consist of 3.4 million doses of MedImmune's nasal-spray product and is likely to reach providers the first week in October, federal health officials said today.
(CIDRAP News) With the health of small businesses at stake in fragile economic times, federal officials and one of the nation's top business groups pushed new efforts this week to help companies prepare for the next wave of the H1N1 pandemic influenza.
Sep 17, 2009
(CIDRAP News) A study in which N95 respirators strongly outperformed surgical masks in shielding hospital workers from influenza viruses and other microbes is being hailed as a landmark in research on respiratory protection for healthcare workers.
Sep 15, 2009
(CIDRAP News) A new study suggests that patients infected with pandemic H1N1 influenza can transmit the live virus longer than previously thought, though it's not clear if the findings will lead to changes in self-isolation recommendations.
(CIDRAP News) The Food and Drug Administration (FDA) today announced approval of four of the five different versions of the pandemic H1N1 vaccine ordered by the US government, helping to pave the way for a vaccination campaign expected to start in October.
(CIDRAP News) – A wide range of research findings on pandemic H1N1 influenza, seasonal flu, and avian flu was presented over the weekend at the 49th annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in San Francisco (www.icaac.org).
Sep 14, 2009
(CIDRAP News) US health officials offered more evidence today that a single dose of pandemic H1N1 influenza vaccines may be enough to protect adults, saying preliminary findings in government-sponsored trials reinforce early results from company trials announced yesterday.
(CIDRAP News) The United States is seeing increased levels of pandemic H1N1 influenza activity, with cases being reported in all 50 states and widespread activity in Guam and 11 states, most of them in the Southeast, the Centers for Disease Control and Prevention said today.
In last week's surveillance report, six states and Puerto Rico reported widespread activity, so the number of states reporting the highest activity has increased by five.
(CIDRAP News) Officials from Roche today said the company is producing Tamiflu (oseltamivir) at near-capacity levels and is collaborating on dozens of research studies, focusing on groups such as pregnant women who are at higher risk of complications from pandemic H1N1 flu.
(CIDRAP News) Preliminary clinical trial results suggest that pandemic H1N1 vaccines made by Novartis and CSL Ltd. will provide protection in adults with just one dose, raising hope for a less difficult immunization program than has been anticipated.
(CIDRAP News) Today was the 12th year the National Foundation for Infectious Diseases (NFID) has held a press conference to discuss its expectations for the upcoming flu season, but discussions were far from routine, reflecting uncertainty surrounding the pandemic flu strain and the complexity of launching two vaccine campaigns.
CDC says H1N1 virus has claimed 47 children's lives
Editor's note: It’s here; the novel H1N1 influenza is rapidly morphing into its second wave assault. We’re all making our last-minute plans for response and preparedness an immediate reality. One of the most important actions we can take right now to reduce H1N1 transmission in the workplace is to keep infected employees out!
(CIDRAP News) As children return to school and promptly become infected with H1N1 influenza, emergency-room (ER) physicians nationwide are becoming increasingly anxious over their ERs' capacity to deal with an influx of flu patients.
